KIN-FAST, NCT05659459: The Trial (KIN001 For Accelerated Symptoms Termination) in Non Hospitalized Patients Infected With SARS-CoV-2 |
|
|
| Suspended | 2 | 400 | Europe | KIN001, Combination Pamapimod 75mg with Pioglitazone 5mg, KIN001-Placebo | Kinarus AG | COVID-19 | 05/25 | 10/25 | | |
| Recruiting | N/A | 1800 | Europe | Statin discontinuation, Intervention arm | Insel Gruppe AG, University Hospital Bern, University of Bern | Statin Treatment for Primary Prevention | 11/26 | 11/26 | | |